anmelden
FTSE All-Share
5.635,05
PKT
+6,27
PKT
+0,11
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.08.12 | Shell (ex Royal Dutch Shell) buy | Nomura | |
| 30.08.12 | Antofagasta hold | Deutsche Bank AG | |
| 30.08.12 | Antofagasta outperform | Exane-BNP Paribas SA | |
| 30.08.12 | BT Group neutral | J.P. Morgan Cazenove | |
| 30.08.12 | Sky overweight | J.P. Morgan Cazenove | |
| 30.08.12 | Aberdeen Group overweight | J.P. Morgan Cazenove | |
| 30.08.12 | Antofagasta sell | UBS AG | |
| 29.08.12 | AstraZeneca neutral | Goldman Sachs Group Inc. | |
| 29.08.12 | BP buy | Deutsche Bank AG | |
| 29.08.12 | GSK neutral | UBS AG | |
| 29.08.12 | Antofagasta sell | Société Générale Group S.A. (SG) | |
| 29.08.12 | Diageo neutral | Citigroup Corp. | |
| 29.08.12 | Aberdeen Group overweight | J.P. Morgan Cazenove | |
| 29.08.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 29.08.12 | Rio Tinto overweight | Morgan Stanley | |
| 29.08.12 | Bunzl sell | UBS AG | |
| 29.08.12 | Diageo overweight | Morgan Stanley | |
| 29.08.12 | AstraZeneca neutral | Sarasin Research | |
| 29.08.12 | Kingfisher underperform | Banc of America Securities-Merrill Lynch | |
| 28.08.12 | GSK neutral | UBS AG | |
| 28.08.12 | GSK buy | Citigroup Corp. | |
| 28.08.12 | AstraZeneca hold | Deutsche Bank AG | |
| 28.08.12 | GSK hold | Deutsche Bank AG | |
| 28.08.12 | Antofagasta outperform | Exane-BNP Paribas SA | |
| 28.08.12 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 28.08.12 | Anglo American equal-weight | Morgan Stanley | |
| 28.08.12 | Intertek buy | Sarasin Research | |
| 27.08.12 | Aberdeen Group sell | Goldman Sachs Group Inc. | |
| 27.08.12 | AstraZeneca hold | Deutsche Bank AG | |
| 27.08.12 | GSK hold | Deutsche Bank AG | |
| 27.08.12 | Diageo halten | Independent Research GmbH | |
| 27.08.12 | Anglo American sector perform | RBC Capital Markets | |
| 24.08.12 | Anglo American buy | UBS AG | |
| 24.08.12 | Aberdeen Group outperform | Exane-BNP Paribas SA | |
| 24.08.12 | Diageo buy | Société Générale Group S.A. (SG) | |
| 24.08.12 | GSK outperform | Exane-BNP Paribas SA | |
| 24.08.12 | Diageo neutral | Exane-BNP Paribas SA | |
| 24.08.12 | Rio Tinto overweight | J.P. Morgan Cazenove | |
| 24.08.12 | Diageo buy | Nomura | |
| 24.08.12 | Anglo American halten | Independent Research GmbH |